You are here:
| Reference : Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel |
| Scientific journals : Article | |||
| Physical, chemical, mathematical & earth Sciences : Chemistry Engineering, computing & technology : Materials science & engineering | |||
| http://hdl.handle.net/2268/3911 | |||
| Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel | |
| English | |
| Danhier, Fabienne [Université catholique de Louvain (UCL), Bruxelles > > Unité de Pharmacie Galénique > >] | |
| Vroman, Benoît [Université catholique de Louvain (UCL), Bruxelles > > Unité de Pharmacie Galénique > >] | |
| Lecouturier, Nathalie [Université catholique de Louvain (UCL), Bruxelles > > Unité de Pharmacie Galénique > >] | |
| Crokart, Nathalie [Université catholique de Louvain (UCL), Bruxelles > > Unité de Pharmacie Galénique > >] | |
| Pourcelle, Vincent [Université catholique de Louvain (UCL) > > Unité de Chimie Organique et Médicinale > >] | |
| Freichels, Hélène [University of Liège (ULg) > Department of Chemistry > Center for Education and Research on Macromolecules (CERM) > >] | |
Jérôme, Christine  [University of Liège (ULg) > Department of Chemistry > Center for Education and Research on Macromolecules (CERM) > >] | |
| Marchand-Brynaert, Jacqueline [Université catholique de Louvain (UCL) > > Unité de Chimie Organique et Médicinale > >] | |
| Feron, Olivier [Université catholique de Louvain (UCL), Bruxelles > > Laboratoire de Pharmacologie et de Thérapeutique > >] | |
| Préat, Véronique [Université catholique de Louvain (UCL), Bruxelles > > Unité de Pharmacie Galénique > >] | |
| 3-Dec-2009 | |
| Journal of Controlled Release | |
| Elsevier Science | |
| 140 | |
| 2 | |
| 166-173 | |
| International | |
| 0168-3659 | |
| 1873-4995 | |
| Amsterdam | |
| The Netherlands | |
| [en] biomaterial ; nanomedecine ; organic nanoparticle | |
| [en] Paclitaxel (PTX)-loaded PEGylated PLGA-based nanoparticles (NP) have been previously described as more effective in vitro and in vivo than Taxol®. The aim of this study was to test the hypothesis that our PEGylated PLGA-based nanoparticles grafted with the RGD peptide or RGD-peptidomimetic (RGDp) would target the tumor endothelium and would further enhance the anti-tumor efficacy of PTX. The ligands were grafted on the PEG chain of PCL-b-PEG included in the nanoparticles. We observed in vitro that RGD-grafted nanoparticles were more associated to Human Umbilical Vein Endothelial cells (HUVEC) by binding to αvβ3 integrin than non-targeted nanoparticles. Doxorubicin was also used to confirm the findings observed for PTX. In vivo, we demonstrated the targeting of RGD and RGDp-grafted nanoparticles to tumor vessels as well as the effective retardation of TLT tumor growth and prolonged survival times of mice treated by PTX-loaded RGD-nanoparticles when compared to non-targeted nanoparticles. Hence, the targeting of anti-cancer drug to tumor endothelium by RGD-labeled NP is a promising approach. | |
| Center for Education and Research on Macromolecules (CERM) | |
| the FRSM ; the Fonds J. Maisin ; the “Région Wallonne” in the frame of the VACCINOR project | |
| Researchers | |
| http://hdl.handle.net/2268/3911 | |
| 10.1016/j.jconrel.2009.08.011 | |
| http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6T3D-4X1YC9S-2-H&_cdi=4944&_user=532038&_orig=browse&_coverDate=12%2F03%2F2009&_sk=998599997&view=c&wchp=dGLbVlb-zSkzk&md5=b4184b42a105ebe137584f1690be09a6&ie=/sdarticle.pdf | |
| http://www.elsevier.com/wps/find/journaldescription.cws_home/502690/description#description | |
| The authors acknowledge Journal of Controlled Release (Elsevier) for allowing them to archive this paper. |
| File(s) associated to this reference | ||||||||||||||
|
Fulltext file(s):
| ||||||||||||||
All documents in ORBi are protected by a user license.
